Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June

Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

Frontiers Genetic contribution of breast cancer genes in women of black African origin

Construction of stemness gene score by bulk and single-cell transcriptome to characterize the prognosis of breast cancer

Frontiers Implementation of multigene panel testing for breast and ovarian cancer in South Africa: A step towards excellence in oncology for the public sector

A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape

William Oh on LinkedIn: Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for…

Managing breast cancer in younger women: challenges and solutions

Multigene Sequencing in Breast Cancer: ESMO Biomarker Factsheet

JPM, Free Full-Text

Prioritizing variants in complete Hereditary Breast and Ovarian Cancer (HBOC) genes in patients lacking known BRCA mutations

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations, BMC Cancer

Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation - ScienceDirect

JPM, Free Full-Text